Suppliers / Daehwa Pharmaceutical Co.,Ltd

Daehwa Pharmaceutical Co.,Ltd

South Korea Updated 9 July 2026

Daehwa Pharmaceutical Co.,Ltd is a finished-dose manufacturer based in South Korea. It appears in 10 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY) and NMPA (CN).

0
active US DMFs
0
valid CEPs
0
registered plants
10
filings across 2 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 7 None
NMPA (CN) 3 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Daehwa Pharmaceutical Co.,Ltd

Does Daehwa Pharmaceutical Co.,Ltd hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Daehwa Pharmaceutical Co.,Ltd. It does have 10 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Daehwa Pharmaceutical Co.,Ltd file?
Filings are on record with NPRA (MY) and NMPA (CN), 10 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Daehwa Pharmaceutical Co.,Ltd comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability